Loading
Life sciences · Journal article
International Journal of Biomedical Research and Innovations · August 22, 2026
Early or partial results. Treat as a signal, not a conclusion.
This scoping review systematically characterised the environmental antimicrobial resistance gene evidence base across Africa from 2010 to 2026, finding that research is geographically concentrated in Nigeria and South Africa, methodologically limited to targeted PCR, and focused on wastewater and hospital effluent. Major evidence gaps persist for Central and West Africa (excluding Nigeria), soil and wildlife reservoirs, and metagenomic characterisation; the authors conclude that standardised multi-compartment One Health surveillance combined with metagenomic capacity is urgently needed.
Scoping review following Joanna Briggs Institute (JBI) methodology and PRISMA Extension for Scoping Reviews (PRISMA-ScR). Studies conducted in African countries that analysed environmental samples and reported molecular detection of antimicrobial resistance genes.. 18 African countries; Nigeria (n=28 studies), South Africa (n=15 studies), and 16 other countries; no Central African countries identified..
Seventy-three studies from 18 African countries met inclusion criteria; Nigeria (n=28, 38%) and South Africa (n=15, 21%) together accounted for 59% of all studies. Wastewater systems were the most studied reservoir (49%), followed by hospital effluents (22%) and surface water (18%). Forty-seven distinct ARGs were identified; the most frequent were blaCTX-M (58%), sul1 (48%), tetA (44%), and blaTEM (41%).
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review does not directly assess clinical interventions or patient outcomes. Instead, it identifies critical knowledge gaps and methodological limitations in environmental AMR surveillance across Africa, highlighting the need for standardised, integrated surveillance systems and investment in metagenomic capacity to better understand resistance gene dissemination and inform public health strategies.
A scoping review that systematically maps the extent and geographic distribution of environmental ARG evidence across Africa, identifying major gaps and methodological constraints, but not testing interventions or generating new primary data on resistance mechanisms or clinical outcomes.
As stated by the source record.
Quoted from the source exactly as published.
This review does not directly assess clinical interventions or patient outcomes. Instead, it identifies critical knowledge gaps and methodological limitations in environmental AMR surveillance across Africa, highlighting the need for standardised, integrated surveillance systems and investment in metagenomic capacity to better understand resistance gene dissemination and inform public health strategies.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Antimicrobial resistance (AMR) is a priority global health threat. Environmental compartments including wastewater, surface water, soils, and sediments act as important reservoirs for antimicrobial resistance genes (ARGs) and are critical in sustaining and amplifying resistance beyond clinical settings. In Africa, structural factors such as rapid urbanisation, inadequate sanitation infrastructure, unregulated antibiotic use in livestock, and high infectious disease burdens may intensify environmental AMR pressures. Despite this, no comprehensive synthesis of the environmental ARG evidence base across Africa has been undertaken. This scoping review aimed to map the extent, range, and nature of evidence on environmental ARGs across Africa, including the types of reservoirs studied, the ARGs detected, the geographic distribution of research, and the dissemination pathways described. We conducted a scoping review following Joanna Briggs Institute (JBI) methodology and reported in accordance with the PRISMA Extension for Scoping Reviews (PRISMA-ScR) checklist. Six electronic databases (PubMed, Scopus, Web of Science, EMBASE, Google Scholar, African Journals Online) were searched from January 2010 to December 2026. Eligible studies were conducted in African countries, analysed environmental samples (water, wastewater, soil, sediment, manure, aquaculture, or wildlife matrices), and reported molecular detection of ARGs by PCR, qPCR, or sequencing approaches. No quality-based exclusions were applied. Data were extracted using a standardised template and synthesised narratively. Seventy-three studies from 18 African countries met inclusion criteria. Nigeria (n=28, 38%) and South Africa (n=15, 21%) together accounted for 59% of all studies. Wastewater systems were the most studied reservoir (49%), followed by hospital effluents (22%) and surface water (18%). Forty-seven distinct ARGs were identified across all studies; the most frequent were blaCTX-M (58%), sul1 (48%), tetA (44%), and blaTEM (41%). Carbapenemase genes were detected in 11 studies (15%), all from hospital effluent or wastewater. Conventional PCR was used in 74% of studies; no study employed shotgun metagenomics. Only 40% of studies explicitly discussed dissemination pathways, predominantly untreated wastewater discharge and agricultural runoff. No study was identified from Central Africa. Environmental ARG evidence from Africa is geographically concentrated, methodologically constrained by reliance on targeted PCR, and heavily focused on wastewater and hospital effluent matrices. Major gaps persist for Central and West Africa (excluding Nigeria), soil and wildlife reservoirs, and metagenomic characterisation of the environmental resistome. Standardised, multi-compartment, One Health surveillance — combined with investment in metagenomic capacity and evidence-based wastewater interventions — is urgently needed.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.